Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.69
+2.83 (19.04%)
At close: Mar 9, 2026, 4:00 PM EDT
17.69
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT

Dyne Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-446.21-317.42-235.94-168.1-149.29
Upgrade
Depreciation & Amortization
2.051.671.671.681.09
Upgrade
Loss (Gain) From Sale of Assets
0.10.070.12--
Upgrade
Loss (Gain) From Sale of Investments
-1.87-3.64-1.081.312.59
Upgrade
Stock-Based Compensation
45.8545.8619.9715.1817.54
Upgrade
Other Operating Activities
0.280.570.791.66-0.75
Upgrade
Change in Accounts Payable
8.25-8.9622.97-1.2413.7
Upgrade
Change in Other Net Operating Assets
-11.66-10.543.34-4.14-4.45
Upgrade
Operating Cash Flow
-403.21-292.37-188.16-153.65-119.56
Upgrade
Capital Expenditures
-20.71-2.38-0.73-3.07-3.62
Upgrade
Investment in Securities
-8.04-201.784.0490.27-134.27
Upgrade
Investing Cash Flow
-28.75-204.0883.3187.2-137.89
Upgrade
Long-Term Debt Issued
148.26----
Upgrade
Net Debt Issued (Repaid)
148.26----
Upgrade
Issuance of Common Stock
742.61809.954.3237.39157.82
Upgrade
Other Financing Activities
-0.56----
Upgrade
Financing Cash Flow
890.31809.954.3237.39157.82
Upgrade
Net Cash Flow
458.35313.45-50.53-29.05-99.63
Upgrade
Free Cash Flow
-423.92-294.75-188.89-156.71-123.18
Upgrade
Free Cash Flow Per Share
-3.30-3.13-3.17-3.02-2.42
Upgrade
Cash Interest Paid
4.34----
Upgrade
Levered Free Cash Flow
-260.09-189.47-104.23-98.17-66.94
Upgrade
Unlevered Free Cash Flow
-256.22-189.47-104.23-98.17-66.94
Upgrade
Change in Working Capital
-3.4-19.4926.31-5.389.26
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.